Is it Time to Buy Canopy Growth Corp (TSX:WEED) Stock?

Canopy Growth (TSX:WEED) (NYSE:WEED) has given back much of its 2018 gains. Is this cannabis stock oversold?

| More on:

Cannabis stocks have given back much of the big gains they racked up in recent months, which has investors wondering which marijuana companies might be attractive buys today.

Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:WEED) to see if it deserves to be in your portfolio.

Strong medical strategy

Canopy Growth has done a good job of positioning itself to benefit from the wide spectrum of cannabis opportunities emerging in Canada and around the world.

The company’s core focus remains on medical marijuana patients and a variety of potential health-focused applications. Canopy Growth has a number of clinical studies under way that could result in valuable patents and product developments.

The company is the Canadian leader in the medical marijuana market with more than 84,000 registered patients. The early move to acquire Mettrum Health was widely viewed as a game-changer for Canopy Growth. The takeover added key national brands, a large patient base, and important production facilities when cannabis company valuations were significantly lower than today.

Recreational market

The launch of the recreational marijuana market in Canada has hit a few speed bumps, primarily connected to supply issues, which will eventually get sorted out. As the market expands, Canopy Growth should be able to capture a significant piece of the cannabis pie. Recreational marijuana sales in Ontario, the largest market, are currently only allowed through the province’s online store, but retail locations will get the green light next year, and up to 1,000 sites could be approved.

Canopy Growth plans to be a player in the physical retail segment in Ontario, although the government intends to limit the number of locations a single company can own and marijuana producers could have restrictions placed on their ownership levels.

Canopy Growth recently purchased Hiku Brands, a cannabis accessories company, in a move to tap the expected demand in branded goods as cannabis culture goes mainstream across the country.

Beverages

On the consumables side, Canopy Growth is planning to be a major force in the cannabis-infused beverage market. Constellation Brands, a U.S.-based global beer and wine company, owns 38% of Canopy Growth through two investments. The first 9.9% stake was bought for $245 million in the fall of 2017. Constellation Brands increased the ownership of Canopy Growth to 38% with an additional $5 billion investment announced in August.

The two companies are developing products for the Canadian launch of the cannabis-infused drinks market, expected some time in 2019.

International

Canada is a small market compared to the opportunities in Europe and South America. As governments adjust their cannabis regulations, Canopy Growth should benefit. The company already owns a pharmaceutical distribution business in Germany and recently announced plans to spend US$115 million on new production facilities in Spain, Italy, or Greece.

In South America, Canopy Growth has a research and development site in Chile and production facilities in Colombia.

Should you buy?

Canopy Growth should be one of the marijuana companies that survives the expected shakeout. At the time of writing, the stock is down to $42.50 per share compared to $76 in October. Constellation Brands paid $48.60 in August to boost its ownership in the company, so investors who buy now are getting a better deal.

That said, volatility should be expected and the $9.9 billion market capitalization is very high for a company that reported quarterly revenue of less than $25 million in the latest report. If you’re a cannabis bull, it might be worthwhile to start nibbling, but I would keep any position small at this point. We could see more downside before the dust settles on the recent pullback.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »